| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3340134 | Allergologia et Immunopathologia | 2007 | 4 Pages |
Abstract
Our study proves therefore Celecoxib safety on a 72-hour observation period.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
L. Andri, P. Falagiani,